• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚合物辅料对模型药物剂型中治疗药物的药物可利用度过程的影响。第一部分。具有可控崩解和释放时间的制剂。

The influence of polymeric excipients on the process of pharmaceutical availability of therapeutic agents from a model drug form. Part I. In formulations with controlled disintegration and release time.

作者信息

Nachajski Michal Jakub, Zgoda Marian Mikołaj

机构信息

Drug Form Technology Unit, Department of Applied Pharmacy, Medical University in Łodz.

出版信息

Polim Med. 2010;40(2):65-77.

PMID:20649091
Abstract

Pre-formulation research was conducted on the application of Ex. Echinaceae aq. siccum in the production of a quickly disintegrating suspension tablet, a lozenge with kariostatic sugar alcohols (mannitol, sorbitol), and, above all, a solid drug form with controlled release of therapeutic agents included in the extract. Morphological parameters of tablets obtained in the course of experiment were estimated and the profiles of the release (diffusion) ofhydrophilic therapeutic agents into model receptor fluids with varying values of osmolarity (0.1 mol HCl approximately 200 mOsm/l, hypotonic hydrating fluid approximately 143 mOsm/l, and compensatory paediatric fluid approximately 272 mOsm/l) were examined. The study focused on the technological problem of determining the effect of hydrogel Carbopol structure on the ordering of diffusion ofhydrophilic therapeutic agents from a model drug form (a tablet) into model fluids with variable osmolarity.

摘要

针对紫锥菊干浸膏在速崩性混悬片、含抑龋糖醇(甘露醇、山梨醇)的含片以及最重要的含提取物中治疗剂控释的固体剂型生产中的应用进行了处方前研究。对实验过程中获得的片剂的形态学参数进行了评估,并研究了亲水性治疗剂在不同渗透压值(0.1 mol HCl约200 mOsm/l、低渗补液约143 mOsm/l和小儿补充液约272 mOsm/l)的模型受体液中的释放(扩散)曲线。该研究聚焦于确定水凝胶卡波姆结构对亲水性治疗剂从模型药物剂型(片剂)扩散到不同渗透压的模型流体中的有序性的影响这一技术问题。

相似文献

1
The influence of polymeric excipients on the process of pharmaceutical availability of therapeutic agents from a model drug form. Part I. In formulations with controlled disintegration and release time.聚合物辅料对模型药物剂型中治疗药物的药物可利用度过程的影响。第一部分。具有可控崩解和释放时间的制剂。
Polim Med. 2010;40(2):65-77.
2
[Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].[双氯芬酸钠缓释制剂中所选药物的技术和药物治疗特性]
Polim Med. 2012;42(2):121-32.
3
[The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].[天然及合成亲水性聚合物在不同释放曲线盐酸二甲双胍片制剂中的应用]
Polim Med. 2012;42(3-4):167-84.
4
[A comparative analysis of the influence of different types of Carbopol on the release rate of lithium-carbonate from matrix tablets].[不同类型卡波姆对基质片剂中碳酸锂释放速率影响的比较分析]
Vojnosanit Pregl. 2012 Aug;69(8):675-80. doi: 10.2298/vsp101015006t.
5
Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug.布洛芬 - 卡波姆974P - NF控释骨架片的处方设计与体外评价。III:辅料对药物释放速率的影响。
J Control Release. 1998 Jul 31;54(2):185-90. doi: 10.1016/s0168-3659(97)00225-3.
6
Application of silicified microcrystalline cellulose (Prosolv) as a polymer carrier of Epilobium parviflorum Schreb. extract in oral solid drug form.硅化微晶纤维素(Prosolv)作为柳叶菜提取物的聚合物载体在口服固体药物剂型中的应用。
Polim Med. 2007;37(2):21-32.
7
[Application extract of bearberry in the prescription of dermatological hydrogels on Carbopol base].[熊果在卡波姆基质皮肤科水凝胶处方中的应用提取物]
Polim Med. 2010;40(3):11-8.
8
Starch/Carbopol spray-dried mixtures as excipients for oral sustained drug delivery.淀粉/卡波姆喷雾干燥混合物作为口服缓释药物递送的辅料。
J Control Release. 2005 Apr 18;103(3):635-41. doi: 10.1016/j.jconrel.2004.12.022.
9
Dissolution kinetics and physical characterization of three-layered tablet with poly(ethylene oxide) core matrix capped by Carbopol.含聚环氧乙烷核心基质且由卡波姆包衣的三层片的溶出动力学及物理特性
Int J Pharm. 2008 May 22;356(1-2):121-9. doi: 10.1016/j.ijpharm.2008.01.002. Epub 2008 Jan 9.
10
Formulation and evaluation of floating tablet of H2-receptor antagonist.H2受体拮抗剂胃漂浮片的制剂与评价
Drug Dev Ind Pharm. 2015;41(9):1499-511. doi: 10.3109/03639045.2014.959969. Epub 2015 Jul 21.